SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-20-000895
Filing Date
2020-02-14
Accepted
2020-02-14 16:40:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT arrowmark-mrsn123119a1.htm SC 13G/A 52604
  Complete submission text file 0001172661-20-000895.txt   54269
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90033 | Film No.: 20621111
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
ArrowMark Colorado Holdings LLC (Filed by) CIK: 0001483859 (see all company filings)

IRS No.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A